http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2016, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 24 Jul 2015 08:30:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748689.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748689.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748689.html Fri, 24 Jul 2015 08:30:00 -0500 A.30037484 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748689.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748689.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748689.html Fri, 24 Jul 2015 08:30:00 -0500 A.30037484 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748689.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748689.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748689.html Fri, 24 Jul 2015 08:30:00 -0500 A.30037484 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748692.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748692.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748692.html Fri, 24 Jul 2015 08:30:00 -0500 A.30037484 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748692.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748692.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748692.html Fri, 24 Jul 2015 08:30:00 -0500 A.30037484 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748692.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748692.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+USPTO+Notice+of+Allowance+for+Proprietary+Dexamethasone+Phosphate+Formulation/10748692.html Fri, 24 Jul 2015 08:30:00 -0500 A.30037484 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Treats+First+Patient+in+Phase+1b++2a+Trial+of+EGP-437+in+Macular+Edema/10721242.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Treats+First+Patient+in+Phase+1b++2a+Trial+of+EGP-437+in+Macular+Edema/10721242.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Treats+First+Patient+in+Phase+1b++2a+Trial+of+EGP-437+in+Macular+Edema/10721242.html Tue, 14 Jul 2015 08:30:00 -0500 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Treats+First+Patient+in+Phase+1b++2a+Trial+of+EGP-437+in+Macular+Edema/10721242.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Treats+First+Patient+in+Phase+1b++2a+Trial+of+EGP-437+in+Macular+Edema/10721242.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Treats+First+Patient+in+Phase+1b++2a+Trial+of+EGP-437+in+Macular+Edema/10721242.html Tue, 14 Jul 2015 08:30:00 -0500 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715207.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715207.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715207.html Fri, 10 Jul 2015 08:30:00 -0500 EYEG EYEGV VRX http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715207.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715207.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715207.html Fri, 10 Jul 2015 08:30:00 -0500 EYEG EYEGV VRX http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715207.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715207.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715207.html Fri, 10 Jul 2015 08:30:00 -0500 EYEG EYEGV VRX http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715225.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715225.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715225.html Fri, 10 Jul 2015 08:30:00 -0500 EYEG EYEGV VRX http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715225.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715225.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715225.html Fri, 10 Jul 2015 08:30:00 -0500 EYEG EYEGV VRX http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715225.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715225.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Signs+Licensing+Agreement+with+Valeant+Pharmaceuticals+for+EGP-437+Combination+Product+in+Uveitis/10715225.html Fri, 10 Jul 2015 08:30:00 -0500 EYEG EYEGV VRX http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+Positive+Guidance+From+FDA+on+NDA+Filing+Requirements+of+EGP-437+for+the+Treatment+of+Anterior+Uveitis/10515767.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+Positive+Guidance+From+FDA+on+NDA+Filing+Requirements+of+EGP-437+for+the+Treatment+of+Anterior+Uveitis/10515767.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+Positive+Guidance+From+FDA+on+NDA+Filing+Requirements+of+EGP-437+for+the+Treatment+of+Anterior+Uveitis/10515767.html Mon, 04 May 2015 08:30:00 -0500 A.06822034 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+Positive+Guidance+From+FDA+on+NDA+Filing+Requirements+of+EGP-437+for+the+Treatment+of+Anterior+Uveitis/10515767.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+Positive+Guidance+From+FDA+on+NDA+Filing+Requirements+of+EGP-437+for+the+Treatment+of+Anterior+Uveitis/10515767.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+Positive+Guidance+From+FDA+on+NDA+Filing+Requirements+of+EGP-437+for+the+Treatment+of+Anterior+Uveitis/10515767.html Mon, 04 May 2015 08:30:00 -0500 A.06822034 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+Positive+Guidance+From+FDA+on+NDA+Filing+Requirements+of+EGP-437+for+the+Treatment+of+Anterior+Uveitis/10515767.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+Positive+Guidance+From+FDA+on+NDA+Filing+Requirements+of+EGP-437+for+the+Treatment+of+Anterior+Uveitis/10515767.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharma+Receives+Positive+Guidance+From+FDA+on+NDA+Filing+Requirements+of+EGP-437+for+the+Treatment+of+Anterior+Uveitis/10515767.html Mon, 04 May 2015 08:30:00 -0500 A.06822034 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Full+Year+2014+Financial+Results/10420208.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Full+Year+2014+Financial+Results/10420208.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Full+Year+2014+Financial+Results/10420208.html Tue, 31 Mar 2015 17:40:00 -0500 EYEG EYEGV http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Full+Year+2014+Financial+Results/10420208.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Full+Year+2014+Financial+Results/10420208.html for the full story. http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Full+Year+2014+Financial+Results/10420208.html Tue, 31 Mar 2015 17:40:00 -0500 EYEG EYEGV